Abstract
The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit
Volume: 9 Issue: 3
Author(s): A. Walsh and K. Ghori
Affiliation:
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Abstract: The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Export Options
About this article
Cite this article as:
Walsh A. and Ghori K., The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010; 9 (3) . https://dx.doi.org/10.2174/1871523011009030229
DOI https://dx.doi.org/10.2174/1871523011009030229 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Unusual Case of Reversible Empty Sella
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions
Current Vascular Pharmacology Management of Postoperative Nausea and Vomiting in Women Undergoing Major Gynecological Surgery: A Review and Update
Current Drug Therapy Perioperative Management of Obese Parturients
Current Women`s Health Reviews Potential Therapeutic Targets in Cirrhotic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets Prevention of Left Ventricular Remodelling after Acute Myocardial Infarction: An Update
Recent Patents on Cardiovascular Drug Discovery Anticancer Drugs Targeting the Apoptotic Pathway
Medicinal Chemistry Reviews - Online (Discontinued) Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Acute Severe Arterial Hypertension: Therapeutic Options
Current Drug Targets Thyroid Hormones and Cardiovascular System: From Bench to Bedside
Current Drug Therapy Diagnostic Cardiac Catheterization in the Pediatric Population
Current Cardiology Reviews Hibiscus Sabdariffa Linnaeus (Malvaceae), Curcumin and Resveratrol as Alternative Medicinal Agents Against Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review
Current Cardiology Reviews Medical Applications of Collagen and Collagen-Based Materials
Current Medicinal Chemistry Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension
CNS & Neurological Disorders - Drug Targets Colloid Update
Current Pharmaceutical Design Synthesis of Some New Chromeno[2,3-b]pyridine and [1,2,4]Triazolo[1,5- a]quinoline Nucleoside Analogues with Expected Biological Activity
Letters in Organic Chemistry Hyperglycemia and Perioperative Glucose Management
Current Pharmaceutical Design Carbonyl-Scavenging Drugs & Protection Against Carbonyl Stress-Associated Cell Injury
Mini-Reviews in Medicinal Chemistry